For dedicated service to advocate and research communities, as the largest global, non-government funder of ovarian cancer research, having raised over $100 million for research/services and developed and conducted extensive advocacy programs including Survivors Teaching Students® through which ovarian cancer survivors and family members have trained/reached nearly 100,000 medical and other health professions students About the Ovarian Cancer Research Alliance The Ovarian Cancer Research Allian..
Runcie C.W. Chidebe & Project PINK BLUE Founder & Executive Director, Project PINK BLUE Abuja, Nigeria For outstanding advocacy throughout Nigeria and in global forums, including founding Project PINK BLUE—an organization focused on cancer advocacy, oncology training, and research—as well as influencing the establishment of the National Institute for Cancer Research and Treatment, developing numerous programs to serve the most needy, and changing cancer awareness and care throughout ..
Nathalie Dauphin McKenzie, MD (USA) & Innovating Health International (Haiti) Director, Gynecologic Oncology Fellowship Program AdventHealth Cancer Institute Orlando, Florida USA For courageous, ongoing advocacy for survivors-patients in the USA and Haiti, including traveling to Haiti several times a year—at great personal risk—to perform life-saving surgeries (otherwise unavailable) and to train oncologists to do the same, currently primarily through Innovating Health International, a P..
Benda Kithaka is a health advocacy and communications specialist. An alumni of the AORTIC Master Cancer Advocacy Trainer Programme in 2013, her advocacy work includes drafting of the Kenya Cancer Control Strategy (2017–2022), writing the WHO Regional Office for Africa Advocacy For Cervical Cancer Prevention and Control in Africa Facilitator Manual, and training of Expert Trainers of Trainers [ToT] from 10 WHO AFRO Countries in use of its toolkit in Africa (2017). Benda sits on the ASCO Resour..
In 2004, at 30 years old, Miho Katagi was diagnosed with ovarian cancer (Mucinous, Stage Ia). At the time, this mother of a 2-year-old son knew nothing about ovarian cancer and felt anxiety every day. During this time, she found support and encouragement from other ovarian cancer patients she met online. In 2006, when she found out that there were no anti-cancer drugs available and approved in Japan to effectively treat ovarian cancer patients, she and Mami Ikematsu—with the support of many ot..
Venus Ginés is a 27-year breast cancer survivor who survived cancer for the second time in 2017 after 25 years of survivorship. Venus retired last year as a faculty member at Baylor College of Medicine in Houston, Texas, having taught cultural competence and health literacy as well as conducted research on Latino medical mistrust. From her personal experience with cancer and her sister’s untimely death from cervical cancer 9 months after diagnosis, Venus founded Día de la Mujer Latina (DML),..